Bitcoin and Ethereum are holding steady near recent highs. Despite a minor dip, buying interest remains strong. The global crypto market cap has edged down, but trading volumes are up. Analysts suggest the market is in a risk-off mode, with institutional demand providing support. Near-term sentiment hinges on Bitcoin’s key support levels and macro economic cues.Read More
Sun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The deal leverages Organon’s strengths in women’s health, biosimilars, and established brands, aiming for significant growth despite geopolitical concerns. Integration plans and manageable debt are key to the strategic move.Read More
Sun Pharmaceutical Industries’ shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in women’s health. The deal diversifies Sun Pharma’s portfolio into women’s health and biosimilars, with analysts from Morgan Stanley and Motilal Oswal expressing bullish sentiment, while JM Financial remains cautious about long-term value creation.Read More
Geopolitical shifts in West Asia will alter global energy routes for years. Oil prices may stay high. Equity markets are climbing on artificial intelligence hype, not strong company profits. Investors are advised to reduce US stock holdings. Asian markets show better performance. This situation points to long-term structural changes in energy and markets.Read More
Silver prices have plunged nearly Rs 2 lakh from January highs, erasing all 2026 gains amid a stronger dollar, profit booking, and global risk-off sentiment. Experts suggest the correction may offer a gradual buying opportunity, supported by strong industrial demand and persistent supply deficits despite short-term volatility.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
